MarketLens MarketLens
US: 2026-08-12 NSE: 2026-08-12 2026-08-12
Neutral
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

GALT Galectin Therapeutics Inc.

TradingView As Of 8/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
3.2000
Day %
3.06%
RS
N/A
Ind Rank
#51
RS 1D
N/A
RS 1W
N/A
RS 1M
N/A
RS 3M
N/A
RS 6M
N/A
Consensus Rating
Buy
Current Quarter EPS
-0.10
Next Quarter EPS
N/A
Current Year EPS
-0.49
Next Year EPS
-0.41
ExchangeUS
Market Cap0 B
52W High7.1300
From 52W High-55.12%
Open3.1200
High3.2600
Low3.1200
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-08-11
Bars Available310
Scanner Hits1
Last Scanner Hit2026-07-13

Recent Scanner History

1 matching / 1 total
Reset
Date Scanner RS
2026-07-13 4% Breakout
US_FOUR_PERCENT_BREAKOUT
N/A

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Buy -0.10 N/A -0.49 -0.41
Based on 1 analysts offering recommendations for 'GALT'.

Quarterly EPS Forecasts

1 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2025 -0.10 -0.10 -0.10 1
0 0

Yearly EPS Forecasts

3 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2025 -0.49 -0.49 -0.49 1
0 0
Dec 2026 -0.41 -0.41 -0.41 1
0 0
Dec 2027 -0.45 -0.45 -0.45 1
0 0